Готові списки джерел за темами / 325.366 83

Добірка наукової літератури з теми "325.366 83"

Автор: Grafiati
Опубліковано: 16 травня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "325.366 83".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Зміст

  1. Статті в журналах
  2. Книги
  3. Частини книг
  4. Тези доповідей конференцій

Статті в журналах з теми "325.366 83":

1

Looi, Khang-Li, Nigel Lever, Andrew Gavin, and Robert Doughty. "Impact of cardiac resynchronisation therapy on burden of hospitalisations and survival: a retrospective observational study in the Northern Region of New Zealand." BMJ Open 9, no. 5 (May 2019): e025634. http://dx.doi.org/10.1136/bmjopen-2018-025634.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
ObjectiveCardiac resynchronisation therapy (CRT) devices have been shown to improve heart failure (HF) symptoms, survival and improve quality of life (QoL). We evaluated the overall impact of CRT on recurrent hospitalisations and survival in real-world patients with HF.DesignRetrospective observational study.SettingNorthern region of New Zealand.ParticipantsPatients with HF who underwent CRT device implantation in between 2008 and 2014 were followed up for 1 year.InterventionsCRT.Primary and secondary outcomes measuredSurvival, all-cause hospitalisations, length of stay, from which days alive and out of hospital (DAOH) were calculated.Results177patients were included, of whom eight died (4.5%) within 1 year of follow-up. Pre-CRT implantation, 83% of all patients had been hospitalised for a total 248 hospitalisation events. Following CRT, 47 patients (27%) were readmitted to hospital within 1 year (total of 98 admissions; p<0.01 compared with pre-device implant). Length of hospital stay was significantly shorter than in the year prior to CRT implantation at a median of 4 (IQR 2–6) vs 7 (IQR 3.5–10.5) days (p=0.03). An increase in the median number of DAOH was observed from 362 (IQR 355–364) to 365 (IQR 364–365) (p<0.01) after CRT implant. The improvement in DAOH was seen regardless of gender and type of CRT devices. Greater DAOH was also seen in those with non-ischaemic cardiomyopathy and Caucasians.ConclusionAfter CRT implant, patients with HF have greater DAOH with reduction of total hospitalisation and fewer hospital days. These results support CRT devices use as a treatment option for appropriate HF patients. DAOH represents an easily measured, patient-centred endpoint that may reflect effectiveness of interventions in future CRT studies.
2

Zhang, Zhong-Bin, Jun-Xiang Wan, Pin Sun, and Zhao-Lin Xia. "Relation of genetic polymorphism in hMTH1c.83, hOGG1c.326 and hMYHc.335 with risks of chronic benzene poisoning." Toxicology Letters 164 (September 2006): S283—S284. http://dx.doi.org/10.1016/j.toxlet.2006.07.248.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Kyriakis, S. C., V. Vassilopoulos, I. Demade, W. Kissels, Z. Polizopoulou, and C. K. Milner. "The effect of virginiamycin on sow and litter performance." Animal Science 55, no. 3 (December 1992): 431–36. http://dx.doi.org/10.1017/s0003356100021139.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
AbstractThe present paper discusses the results of a trial study, which was carried out to demonstrate the potential beneficial effects of virginiamycin (VM) on sow and litter performance. VM was added to the sow food at the levels of 0, 20 and 40 mg/kg, for a period of two breeding cycles, covering pregnancy and lactation. VM supplementation of the sow food improved sow performance by: (i) decreasing sow weight loss from farrowing to weaning (first period: 8·78 v. 3·54 v. 2·88 kg, P < 0·05; second period: 8·98 v. 3·93 v. 2·32 kg, P < 0·05), (ii) decreasing the duration of the reproductive cycle (first period: 154·5 v. 152·2 v. 151·2 days, P < 0·05; second period: 153·8 v. 151·5 v. 250·6 days, P < 0·05) and (in) increasing milk fat content (second period: 63·7 v. 81·3 v. 83·3 g/kg, P<0·05). Litter performance was also improved in terms of: (i) litter size at weaning (first period: 8·16 v. 8·88 v. 9·18, P < 0·05; second period: 8·98 v. 9·30 v. 9·76, P < 0·05), (ii) body weight at weaning (first period: 5·78 v. 6·29 v. 6·56 kg, P < 0·05; second period: 5·88 v. 6·38 v. 6·60 kg, P < 0·05), (Hi) average daily gain (first period: 172 v. 189 v. 197 g, P < 0·05; second period: 178 v. 292 v. 198 g, P < 0·05) and (iv) food conversion ratio (first period: 0·356 v. 0·331 v. 0·324, P < 0·05; second period: 0·363 v. 0·334 v. 0·325, P < 0·05). These beneficial effects of VM were more pronounced at the higher of the two inclusion levels.
4

Oliveira, Emídio Cantídio Almeida de, Fernando José Freire, Ruthanna Isabelle de Oliveira, Maria Betânia Galvão dos Santos Freire, Djalma Euzébio Simões Neto, and Silas Alves Monteiro da Silva. "Extração e exportação de nutrientes por variedades de cana-de-açúcar cultivadas sob irrigação plena." Revista Brasileira de Ciência do Solo 34, no. 4 (August 2010): 1343–52. http://dx.doi.org/10.1590/s0100-06832010000400031.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
A pesquisa tecnológica para suporte do setor sucroalcooleiro nacional mostra que são esporádicos os trabalhos desenvolvidos com cana-de-açúcar irrigada envolvendo a exigência nutricional. Nesse contexto, objetivou-se quantificar, durante o ciclo de cana-planta de 11 variedades de cana-de-açúcar (SP79-1011, RB813804, RB863129, RB872552, RB943365, RB72454, RB763710, SP78-4764, SP81-3250, RB867515 e RB92579) cultivadas sob irrigação plena, a capacidade de extração e exportação de N, P, K, Ca e Mg, bem como a exigência nutricional para produção de uma tonelada de colmo por hectare (TCH). A pesquisa foi realizada em campo, no município de Carpina, PE, durante a safra agrícola 2006/2007. O delineamento experimental empregado foi de blocos casualizados, com 11 tratamentos e quatro repetições. A extração e exportação de nutrientes, assim como a exigência nutricional, foram avaliadas aos 360 dias após o plantio (DAP) na parte aérea das plantas. A extração de nutrientes na parte aérea da cana-planta apresentou, em média, valores de 179, 25, 325, 226 e 87 kg ha-1 de N, P, K, Ca e Mg, respectivamente, o que proporcionou a seguinte ordem decrescente de extração: K > Ca > N > Mg > P. A exportação média de N, P, K, Ca e Mg pelo colmo das variedades irrigadas foi de 92; 15; 188; 187; e 66 kg ha-1; correspondendo, respectivamente, a 51, 60, 58, 83 e 76 % de todo o nutriente extraído na parte aérea da cana-planta, com destaque para as variedades RB92579 e SP81-3250 para o N, RB813804, RB863129, RB872552, RB763710, RB92579, SP78-4764, SP81-3250 e SP79-1011 para o P, SP79-1011, SP81-3250, RB813804, RB872552 e RB763710 para o K, RB92579 e RB863129 para o Ca e RB92579 para o Mg. Para produção de uma TCH, foram exigidos pelas variedades durante o ciclo de cana-planta valores médios de 0,91; 0,13; 1,71; 1,18; e 0,44 kg de N, P, K, Ca e Mg, respectivamente.
5

Wang, P., M. Reed, Y. Wang, G. Mayr, J. E. Stenger, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. "p53 domains: structure, oligomerization, and transformation." Molecular and Cellular Biology 14, no. 8 (August 1994): 5182–91. http://dx.doi.org/10.1128/mcb.14.8.5182-5191.1994.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Wild-type p53 forms tetramers and multiples of tetramers. Friedman et al. (P. N. Friedman, X. B. Chen, J. Bargonetti, and C. Prives, Proc. Natl. Acad. Sci. USA 90:3319-3323, 1993) have reported that human p53 behaves as a larger molecule during gel filtration than it does during sucrose gradient sedimentation. These differences argue that wild-type p53 has a nonglobular shape. To identify structural and oligomerization domains in p53, we have investigated the physical properties of purified segments of p53. The central, specific DNA-binding domain within murine amino acids 80 to 320 and human amino acids 83 to 323 behaves predominantly as monomers during analysis by sedimentation, gel filtration, and gel electrophoresis. This consistent behavior argues that the central region of p53 is globular in shape. Under appropriate conditions, however, this segment can form transient oligomers without apparent preference for a single oligomeric structure. This region does not enhance transformation by other oncogenes. The biological implications of transient oligomerization by this central segment, therefore, remain to be demonstrated. Like wild-type p53, the C terminus, consisting of murine amino acids 280 to 390 and human amino acids 283 to 393, behaves anomalously during gel filtration and apparently has a nonglobular shape. Within this region, murine amino acids 315 to 350 and human amino acids 323 to 355 are sufficient for assembly of stable tetramers. The finding that murine amino acids 315 to 360 enhance transformation by other oncogenes strongly supports the role of p53 tetramerization in oncogenesis. Amino acids 330 to 390 of murine p53 and amino acids 340 to 393 of human p53, which have been implicated by Sturzbecher et al. in tetramerization (H.-W. Sturzbecher, R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins, Oncogene 7:1513-1523, 1992), do not form stable tetramers under our conditions. Our findings indicate that p53 has at least two autonomous oligomerization domains: a strong tetramerization domain in its C-terminal region and a weaker oligomerization domain in the central DNA binding region of p53. Together, these domains account for the formation of tetramers and multiples of tetramers by wild-type p53. The tetramerization domain is the major determinant of the dominant negative phenotype leading to transformation by mutant p53s.
6

Wang, P., M. Reed, Y. Wang, G. Mayr, J. E. Stenger, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. "p53 domains: structure, oligomerization, and transformation." Molecular and Cellular Biology 14, no. 8 (August 1994): 5182–91. http://dx.doi.org/10.1128/mcb.14.8.5182.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Wild-type p53 forms tetramers and multiples of tetramers. Friedman et al. (P. N. Friedman, X. B. Chen, J. Bargonetti, and C. Prives, Proc. Natl. Acad. Sci. USA 90:3319-3323, 1993) have reported that human p53 behaves as a larger molecule during gel filtration than it does during sucrose gradient sedimentation. These differences argue that wild-type p53 has a nonglobular shape. To identify structural and oligomerization domains in p53, we have investigated the physical properties of purified segments of p53. The central, specific DNA-binding domain within murine amino acids 80 to 320 and human amino acids 83 to 323 behaves predominantly as monomers during analysis by sedimentation, gel filtration, and gel electrophoresis. This consistent behavior argues that the central region of p53 is globular in shape. Under appropriate conditions, however, this segment can form transient oligomers without apparent preference for a single oligomeric structure. This region does not enhance transformation by other oncogenes. The biological implications of transient oligomerization by this central segment, therefore, remain to be demonstrated. Like wild-type p53, the C terminus, consisting of murine amino acids 280 to 390 and human amino acids 283 to 393, behaves anomalously during gel filtration and apparently has a nonglobular shape. Within this region, murine amino acids 315 to 350 and human amino acids 323 to 355 are sufficient for assembly of stable tetramers. The finding that murine amino acids 315 to 360 enhance transformation by other oncogenes strongly supports the role of p53 tetramerization in oncogenesis. Amino acids 330 to 390 of murine p53 and amino acids 340 to 393 of human p53, which have been implicated by Sturzbecher et al. in tetramerization (H.-W. Sturzbecher, R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins, Oncogene 7:1513-1523, 1992), do not form stable tetramers under our conditions. Our findings indicate that p53 has at least two autonomous oligomerization domains: a strong tetramerization domain in its C-terminal region and a weaker oligomerization domain in the central DNA binding region of p53. Together, these domains account for the formation of tetramers and multiples of tetramers by wild-type p53. The tetramerization domain is the major determinant of the dominant negative phenotype leading to transformation by mutant p53s.
7

Ceponis, M. J., and R. A. Cappellini. "Wholesale and Retail Losses in Grapefruit Marketed in Metropolitan New York." HortScience 20, no. 1 (February 1985): 93–95. http://dx.doi.org/10.21273/hortsci.20.1.93.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Abstract Losses in white- and red-flesh grapefruit (Citrus paradisi Macf.) retailed in metropolitan New York during 1981-83 were 3.6%. There was no difference between the 2 types of fruit. Florida-grown grapefruit had a retail cullage loss of 3.5%. No significant difference in loss occurred between store-prepackaged and loose fruit during retail. Parasitic diseases were responsible for almost half of the culls; rind breakdown and mechanical damage accounted for most of the remainder. Sampling at the wholesale level revealed a potential cullage of 1.4%.
8

Suharsa, Suharsa, and Rambat Sasongko. "Proyeksi Kebutuhan Guru IPA SMP Negeri Di Kabupaten Bengkulu Selatan Tahun 2020 – 2024." Manajer Pendidikan: Jurnal Ilmiah Manajemen Pendidikan Program Pascasarjana 14, no. 3 (December 27, 2020): 6–15. http://dx.doi.org/10.33369/mapen.v14i3.12828.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Abstrak: Penelitian ini bertujuan untuk mendeskripsikan proyeksi kebutuhan guru IPA SMP di Kabupaten Bengkulu Selatan Tahun 2020-2024. Penelitian ini merupakan penelitian proyeksi dengan metode pendekatan deskriptif kuantitatif. Subjek penelitian ini adalah guru IPA Sekolah Menengah Pertama di Kabupaten Bengkulu Selatan. Pengumpulan data diperoleh dari Dinas Pendidikan dan Kebudayaan Kabupaten Bengkulu Selatan. Metode pengumpulan data menggunakan dokumentasi data sekunder. Analisis data menggunakan teknik proyeksi. Hasil penelitian proyeksi kebutuhan guru IPA SMP di Kabupaten Bengkulu Selatan tahun 2020-2024 menunjukkan bahwa; (1) Jumlah guru IPA 2019/2020 sebanyak 78 orang. Tuntutan guru ada 80 orang jadi ada kekurangan 2 orang, (2) proyeksi jumlah rombel tahun 2020 ada 316 rombel, tahun 2021 ada 321 rombel, tahun 2022 ada 323 rombel, tahun 2023 ada 327 rombel , dan tahun 2024 ada 330 rombel, (3) proyeksi kebutuhan guru IPA tahun 2020 sebanyak 81 orang ada kekurangan 8 orang, tahun 2021 sebanyak 82 orang ada kekurangan sebanyak 13 orang, di 2022 dibutuhkan 82 orang ada kekurangan sebanyak 20 orang, tahun 2023 dibutuhkan 83 orang ada kekurangan sebanyak 26 orang, dan pada tahun 2024 dibutuhkan sebanyak 84 orang ada kekurangan sebanyak 31 orang. Kata kunci: proyeksi kebutuhan, guru IPA
9

Hoffman-Censits, Jean H., Edouard John Trabulsi, David Y. T. Chen, Alexander Kutikov, Jianqing Lin, Rosalia Viterbo, Gary R. Hudes, et al. "Neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) in patients with high-grade upper-tract urothelial carcinoma." Journal of Clinical Oncology 32, no. 4_suppl (February 1, 2014): 326. http://dx.doi.org/10.1200/jco.2014.32.4_suppl.326.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
326 Background: Improved safety and response rates of AMVAC over standard MVAC in patients (pts) with metastatic bladder cancer support study of neoadjuvant AMVAC for pts with muscle invasive bladder cancer (MIBC) and prenephroureterectomy (NU) for pts with high-grade upper-tract urothelial cancer (UTUC). We performed a phase II study of neoadjuvant AMVAC in MIBC and UTUC, and herein report the results of the UTUC exploratory subgroup. Methods: Pts with UTUC (ureter or renal pelvis) with high-grade UC on biopsy, or positive urine cytology and mass on cross sectional imaging, N0-N1, CrCl >=50, adequate hepatic and marrow function were eligible. Pts received 3 cycles of AMVAC (methotrexate 30 mg/m2, vinblastine 3 mg/m2, doxorubicin 30 mg/m2, cisplatin 70mg/m2) day 1, pegfilgrastim 6 mg day 2 or 3, every 2 weeks. NU, with lymph node dissection at surgeon discretion, was performed 4-8 weeks after last cycle. Exploratory endpoint was pathologic complete response (pCR) rate. Results: Accrual is complete with 10 evaluable UTUC pts enrolled at 2 institutions (FCCC, TJU) over 46.5 months. Median age 67 (range 49-83). Of 10 pts, 6 completed all 3 cycles of AMVAC. Four pts received < 3 cycles due to grade 3 acute kidney injury (1), pyelonephritis and grade 3 diverticulitis (1), flare of underlying hepatitis (1), grade 3 fatigue (1). Additional related grade 3 adverse events (AE) were anemia (1) and nausea/vomiting (1), no grade 4 or 5 AE. All pts underwent NU within 8 weeks of last chemotherapy, median 5.5 weeks. Median time from day 1 AMVAC to NU was 9 wks. 1/10 pts had a pCR, 4/10 patients were staged <pT1, 2/10 pT2, and 3/10 >pT3 or N+. An additional 21.5 months of enrollment were needed in this expansion cohort to accrue 10 pts with UTUC, compared to 44 MIBC pts in 25 mos. All pts completed study treatment as of July 2013. Conclusions: In this small sample, neoadjuvant AMVAC prior to NU was clinically active with manageable toxicity. With short duration from start of chemotherapy to NU, 3 neoadjuvant AMVAC cycles should be considered for further study for high-grade UTUC prior to NU in the cooperative group setting. Clinical trial information: NCT01031420.
10

Studenikina, L. N., S. Y. Domareva, Y. E. Golenskikh, and A. V. Matveeva. "Features of high-filled composites based on various brands of polyvinyl alcohol." Proceedings of the Voronezh State University of Engineering Technologies 83, no. 1 (June 3, 2021): 316–22. http://dx.doi.org/10.20914/2310-1202-2021-1-316-322.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Composites based on polyvinyl alcohol (PVA) and polysaccharides (PS) have significant potential for use as compostable packaging materials, as well as in various fields of crop production. PVS are produced by the industry of various brands that differ in molecular weight (MM) and the residual content of vinyl acetate (BA) groups, and as a result - the degree of hydrolysis. Depending on the brand of PVA and the nature of the filler, such properties of composites based on them as water resistance, strength, degree of bioconversion, etc.will differ significantly. The purpose of the work: a comprehensive assessment of the properties of high-filled composites based on PVA of various brands, differing in the degree of hydrolysis, and polysaccharides. Objects of research: composites obtained by direct combination of a 5% solution of PVA (grades 1799, VS-05, BP-05, KurarayPoval 3-83) and PS powder (wood microcellulose - MCD, corn native starch - KK), with and without the addition of a plasticizer (P) - glycerin, followed by dehydration in air or in a vacuum drying cabinet. Based on the presence of external defects after dehydration and the strength characteristics of the material, it was found that for PVA-1799 it is possible to achieve a filling degree of 80 vol.%, for a PVA BP-05, VS-05 KurarayPoval and 3-83-no more than 50 vol.% without plasticizer and up to 70 vol.% in the presence of a plasticizer. It is noted that when filling PVA with starch up to 50 vol.% dehydrated composites are transparent or semi-transparent, which gives them additional advantages as packaging materials (including film). For composites based on PVA-1799, it was found that the maximum water absorption (250% by weight) has a PVA filled with MCD (20: 80 vol.%), and the introduction of a plasticizer (5 vol.% ) significantly reduces the degree of water absorption (up to 150% by weight), which is not typical for this brand of PVA filled with CC (water absorption was about 50% by weight with and without plasticizer). Composites based on PVA grades VS-05, BP-05, KurarayPoval 3-83 dissolve in water at room temperature for 5-10 minutes. During the preliminary assessment of the biodegradation of the studied PVA-1799 composites, it was found that micro-cracks and areas with immobilized microbiota were observed in the polymer matrix during microscopy after 6 months of composting and soil testing, however, no significant damage to the integrity of the polymer of this brand occurred during the specified composting period, which emphasizes the complex nature of the biodegradation of PVA with high MM and low content of VA groups.
Більше джерел
Також вас можуть зацікавити розширені добірки на тему "325.366 83" для конкретних типів джерел:
Статті в журналах

Книги з теми "325.366 83":

1

United States. Congress. Senate. Committee on Finance. Subcommittee on Energy and Agricultural Taxation. Energy tax incentives: Hearing before the Subcommittee on Energy and Agricultural Taxation of the Committee on Finance, United States Senate, One Hundred Second Congress, first session, on S. 26, S. 83, S. 129, S. 141, S. 201, S. 326, S. 466, S. 661, S. 679, S. 731, S. 741, S. 743, S. 992, S. 1157, and S. 1178, June 13 and 14, 1991. Washington: U.S. G.P.O., 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Haynes, John Harold. B. M. W. 316, 320 and 320i 1975-83 Owner's Workshop Manual. Haynes Manuals Inc, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Bajki o dinozaurach. Dragon, 2020.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Jadzia Pętelka czuje złość. Zielona Sowa, 2022.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Tureckie nadzieje. Prószyński Media, 2022.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Klara i słońce. Albatros, 2021.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kuku Król. Warszawa, Poland: Dwukropek, 2021.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "325.366 83":

1

"W. Dahr, in Recent Advance in Blood Group Biohchemistrv, V. Vengelen-Tyler and W.J. Judd, eds. American Association of Blood Banks, Arlington, VA (1986) pp. 23-65. 32. J-P. Cartron, in Monoclonal antibodies against human red blood cell and related antigens. P. Rouger and C. Salmon, eds. Arnette, Paris (1987) pp. 69-97. 33. D.J. Anstee, Vox Sang., 58, 1-20 (1990). 34. P. Tippett, in Blood Group Systems: Rh. V. Vengelen-Tyler and S. Pierce, eds. American Association of Blood Banks, Arlington, VA (1987) pp. 25-53 35. C. Lomas, J. Poole, N. Salaru, M. Redman, K. Kirkley, M. Moulds, J. McCreary, G.S. Nicholson, H. Hustinx and C. Green, Vox Sang., 59, 39-43 (1990). 36. J. Poole, H. Hustinx, H. Gerber, C. Lomas, Y.W. Liew, and P. Tippett, Vox Sang., 59, 44-47 (1990). 37. M. Bizot, C. Lomas, F. Rubio and P. Tippett, Transfusion, 28, 342-345 (1988). 38. N.A. Ellis, T-Z. Ye, S. Patton, J. German, P.N. Goodfellow and P. Weller, Nature Genet., 6, 394-400 (1994). 39. C. Gelin, F. Aubrit, A. Phalipon, B. Raynal, S. Cole, M. Kaczorek and A. Bernard, EMBO J., 8, 3253-3259 (1989). 40. M.N. Dworzak, G. Fritsch, P. Buchinger, C. Fleischer, D. Printz, A. Zellner, A. Schollhammer, G. Steiner, P.F. Ambros and H. Gadner, Blood, 83, 415-425 (1994). 41. R. Levy, J. Dilley, R.l. Fox and R. Warnke, Proc. Natl. Acad. Sci. USA, 76, 6552-6556 (1979). 42. G.S. Banting, B. Pym, S.M. Darling and P.N. Goodfellow, Mol Immunol., 26, 181-188 (1989). 43. P. Goodfellow, G. Banting, D. Sheer, H.H. Ropers, A. Caine, M.A. Ferguson-Smith, S. Povey and R. Voss, Nature, 302. 346-349 (1983). 44. S.M. Darling, G.S. Banting, B. Pym, J. Wolfe and P.N. Goodfellow, Proc. Natl. Acad. Sci. USA, 83, 135-139 (1986). 45. P.N. Goodfellow and P. Tippett, Nature, 289. 404-405 (1981). 46. P. Tippett, M-A. Shaw, C.A. Green and G.L. Daniels, Ann. Hum. Genet., 50, 339-347 (1986). 47. G.S. Banting, B. Pym and P.N. Goodfellow, EMBO J., 4, 1967-1972 (1985). 48. F. Latron, D. Blanchard and J-P. Cartron, Biochem. J., 247, 757-764 (1987). 49. R. Herron and G.A. Smith, Biochem. J., 262. 369-371 (1989). 50. A.C. Petty and P. Tippett Submitted." In Transfusion Immunology and Medicine, 200–205. CRC Press, 1995. http://dx.doi.org/10.1201/9781482273441-18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "325.366 83":

1

Catano, Joanna, and Miguel A. Pando. "Static and Dynamic Properties of a Calcareous Sand from Southwest Puerto Rico." In GeoFlorida 2010. Reston, VA: American Society of Civil Engineers, 2010. http://dx.doi.org/10.1061/41095(365)83.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

До бібліографії